SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-19-000009
Filing Date
2019-02-11
Accepted
2019-02-11 16:12:43
Documents
5
Period of Report
2019-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-kwarrantsexercise.htm 8-K 30673
2 EXHIBIT 4.1 exhibit41reloadpublicoffer.htm EX-4.1 94699
3 EXHIBIT 4.2 exhibit42reloadwim.htm EX-4.2 93838
4 EXHIBIT 10.1 exhibit101repricinglettera.htm EX-10.1 41216
5 EXHIBIT 10.2 exhibit102repricinglettera.htm EX-10.2 41896
  Complete submission text file 0001618835-19-000009.txt   303688
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 19585524
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1